Filing Details

Accession Number:
0001104659-22-003274
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-11 18:22:31
Reporting Period:
2022-01-07
Accepted Time:
2022-01-11 18:22:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Cfo, Evp & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-07 31,776 $14.40 137,818 No 4 M Direct
Common Stock Disposition 2022-01-07 20,000 $24.15 117,818 No 4 S Direct
Common Stock Disposition 2022-01-07 11,776 $24.90 106,042 No 4 S Direct
Common Stock Acquisiton 2022-01-10 16,000 $14.40 122,042 No 4 M Direct
Common Stock Disposition 2022-01-10 16,000 $25.40 106,042 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2022-01-07 31,776 $0.00 31,776 $14.40
Common Stock Employee Stock Option (right to buy) Disposition 2022-01-10 16,000 $0.00 16,000 $14.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
66,777 2024-04-21 No 4 M Direct
50,777 2024-04-21 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 7, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.90 to $24.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price .
  3. Shares subject to the option are fully vested and immediately exercisable.